Asthma
Showing NaN - NaN of 155
Asthma Trial in Worldwide (Tezepelumab (APFS), Tezepelumab (AI))
Completed
- Asthma
- Tezepelumab (APFS)
- Tezepelumab (AI)
-
Hoover, Alabama
- +35 more
Jul 9, 2021
Asthma Trial in Worldwide (FF/UMEC/VI (100/31.25/25) mcg, FF/UMEC/VI (100/62.5/25) mcg, FF/UMEC/VI (200/31.25/25) mcg)
Completed
- Asthma
- FF/UMEC/VI (100/31.25/25) mcg
- +10 more
-
Birmingham, Alabama
- +408 more
Feb 26, 2021
Asthma Trial in United States (Indacaterol maleate, Indacaterol acetate, Placebo)
Completed
- Asthma
- Indacaterol maleate
- +2 more
-
North Dartmouth, Massachusetts
- +5 more
Dec 9, 2020
Asthma Trial in Worldwide (Indacaterol acetate/Mometasone furoate, Mometasone furoate, Salmeterol xinafoate/fluticasone
Completed
- Asthma
- Indacaterol acetate/Mometasone furoate
- +2 more
-
Birmingham, Alabama
- +389 more
Feb 21, 2020
Asthma Trial in United States (Generic Budesonide/Formoterol Fumarate Dihydrate, Symbicort® (Budesonide/Formoterol Fumarate
Completed
- Asthma
- Generic Budesonide/Formoterol Fumarate Dihydrate
- +2 more
-
Surprise, Arizona
- +16 more
Nov 11, 2019
Diabetes, Asthma, Pulmonary Disease, Chronic Obstructive Trial in Worldwide (Human Insulin Inhalation Powder, injected insulin)
Completed
- Diabetes Mellitus
- +2 more
- Human Insulin Inhalation Powder
- injected insulin
-
Montgomery, Alabama
- +100 more
Sep 9, 2019
Asthma Trial in United States (AS MDI 90 µg, AS MDI 180 µg, Placebo MDI)
Completed
- Asthma
- AS MDI 90 μg
- +4 more
-
Rolling Hills Estates, California
- +9 more
Jul 23, 2019
Asthma Trial in Canada, United States (Fluticasone furoate/ Vilanterol 100 mcg/25 mcg, Fluticasone propionate 250 mcg, Placebo
Completed
- Asthma
- Fluticasone furoate/ Vilanterol 100 mcg/25 mcg
- +3 more
-
Huntington Beach, California
- +15 more
Jul 5, 2019
Asthma Trial in Worldwide (NVA237 (glycopyrronium bromide), Placebo)
Completed
- Asthma
- NVA237 (glycopyrronium bromide)
- Placebo
-
North Dartmouth, Massachusetts
- +20 more
Jan 15, 2019